AMS •
Healthcare •
Biotechnology •
Quote as of 07/24/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeAMS
Market Capitalization848.92 mln
Float706 mln
Earnings Date07/30/2026
EPS
0.02
Overpriced
P / E
55.20
Richly valued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.81
Likely reliable
1-Year Forecast
2.38
Transformational upside
Relative Strength
4
/ 100
Severely lagging
Business Description
Pharming Group N.V. is a Dutch medicine company founded in 1988 and based in Leiden, the Netherlands, that creates and sells treatments for rare genetic conditions across the United States, Europe, and other markets. Its two main products are RUCONEST, used to treat sudden episodes of hereditary angioedema, and Joenja, a daily pill that helps patients with a rare immune system disorder called activated PI3K delta syndrome. The company works alongside Novartis under a formal development and licensing partnership to advance its pipeline of specialized treatments.
